• LAST PRICE
    0.0018
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0018
  • Day Range
    ---
  • 52 Week Range
    Low 0.0005
    High 0.0047
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.0017
TimeVolumePHBI
09:37 ET17786340.001675
09:39 ET7308500.0016
09:42 ET20000.0019
10:33 ET90000.0018
10:36 ET80000.0018
10:38 ET100000.0017
10:40 ET20000.0018
10:49 ET7140.0017
10:51 ET10000.0018
12:08 ET769230.0017
01:04 ET5550.0019
01:20 ET1000.0019
02:39 ET150000.0019
02:50 ET4000000.0019
03:15 ET700000.0017
03:17 ET5550.0019
03:32 ET237050.0018
03:53 ET20000.0018
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPHBI
Pharmagreen Biotech Inc
1.1M
-2.6x
---
United StatesADXS
Ayala Pharmaceuticals Inc
1.2M
0.0x
---
United StatesGCTK
GlucoTrack Inc
1.4M
-0.1x
---
United StatesPXMD
PaxMedica Inc
795.3K
0.0x
---
United StatesCWBR
CohBar Inc
1.5M
-0.1x
---
United StatesPCNT
Point of Care Nano-Technology Inc
726.9K
0.0x
---
As of 2024-11-29

Company Information

Pharmagreen Biotech, Inc. is a Canada-based company. The Company is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a wide variety of ailing conditions. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle with 60 enteric capsules. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its other nutraceutical products are in various development stages. Its subsidiaries include WFS Pharmagreen Inc, and 1155097 BC Ltd.

Contact Information

Headquarters
2987 Blackbear CrtCOQUITLAM, BC, Canada V3E 3A2
Phone
404-671-9253
Fax
---

Executives

President, Director; Chief Executive Officer, Director of WFS Pharmagreen Inc.
Peter Wojcik
Chief Financial Officer, Director of WFS Pharmagreen Inc.
Terry Kwan
Chief Operating Officer of WFS Pharmagreen Inc.
Fawzia Afreen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1M
Revenue (TTM)
$4.4K
Shares Outstanding
663.6M
Pharmagreen Biotech Inc does not pay a dividend.
Beta
1.98
EPS
$0.00
Book Value
$0.00
P/E Ratio
-2.6x
Price/Sales (TTM)
258.8
Price/Cash Flow (TTM)
---
Operating Margin
-6,227.29%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.